FDA Inspection
Catalent Pharma Solutions LLCCatalent Pharma Solutions LLC – FDA Inspection, May 22, 2026
Record Details
This FDA Inspection record concerns Catalent Pharma Solutions LLC, with an inspection on May 22, 2026, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 2dc04336-ffa2-402d-9df8-1da741545cff
Inspection Facts
- Inspection number
- 1303072
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Catalent Pharma Solutions LLC
12| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 15, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2019 | Not classified | Atlanta District Office |
Other documents for Catalent Pharma Solutions LLC
- FDA Inspection 1229061 - 2024-05-24
- FDA Inspection 1195585 - 2022-12-15
- FDA Inspection 1131607 - 2020-09-28
- FDA Inspection 1116748 - 2019-12-20
- FDA Inspection 1102199 - 2019-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.